Interaction between DRD 2 and AKT 1 genetic variations on risk of psychosis in cannabis users : a case – control study
暂无分享,去创建一个
M. D. Forti | R. Murray | J. Powell | G. Blasi | A. Bertolino | C. Iyegbe | M. Colizzi | M. Forti | R. Murray
[1] R. Murray,et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. , 2015, Schizophrenia bulletin.
[2] G. Blasi,et al. Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior , 2015, Neuropsychopharmacology.
[3] M. D. Forti,et al. Different Dopaminergic Abnormalities Underlie Cannabis Dependence and Cannabis-Induced Psychosis , 2014, Biological Psychiatry.
[4] L. Kegeles,et al. Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence , 2012, Molecular Psychiatry.
[5] R. Murray,et al. Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users , 2012, Biological Psychiatry.
[6] D. Collier,et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function , 2012, Molecular Psychiatry.
[7] R. Winkel. Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up , 2011 .
[8] G. Blasi,et al. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia , 2010, Proceedings of the National Academy of Sciences.
[9] Fabio Sambataro,et al. Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance , 2010, PloS one.